Metastatic pancreatic neuroendocrine carcinoma causing Cushing's syndrome: ACTH secretion by metastases 3 years after resection of nonfunctioning primary cancer

International Journal of Pancreatology

Volumn 19, Issue 3, 1996, Pages 205-208

  Zhu, Liyin ^a   Domenico, Don R ^a   Howard, John M ^a,b  

^a TOLEDO HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

ACTH secretion by islet cell metastases; Cushing's Syndrome; pancreatic neuroendocrine carcinoma

Indexed keywords

CORTICOTROPIN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING DISEASE; HUMAN; IMMUNOCHEMISTRY; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PANCREAS CARCINOMA; PANCREAS ISLET CELL; PLOIDY; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; CARCINOMA, NEUROENDOCRINE; CUSHING SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SEROTONIN; STAINING AND LABELING;

EID: 0030015956     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Scarpelli DG. The pancreas, in Pathology, 2nd ed, Rubin E, Farber JL, eds. JB Lippincott, Philadelphia, PA, 1994; p. 803.
2. Doppman JL, Nieman LR, Cutler GB Jr, Chrousos GP, Fraker DL, Norton JA, Jensen RT. Adrenocorticotropic hormone-secreting islet cell tumors: Are they always malignant? Radiology 1994; 190: 59-64.
3. Schneider C, Mittelmeier HO, Gebhardt C. Cushing's syndrome from a neuroendocrine pancreatic tumor. Leber Magen Darm 1992; Nov 22(6): 234-236.
4. Sandler M, Rubin PC, Reid JL, Smith GD. Oat cell carcinoma in the pancreas: An unusual cause of Cushing's syndrome. Br J Hosp Med 1992; 47(7): 537-538.
5. Gullo O, DeGiorgio R, D'Errico A, Grigioni W, Parenti M, Corinaldesi R. Pancreatic exocrine carcinoma producing adrenocorticotropic hormone. Pancreas 1992; 7: 172-176.
6. Walter RM, Ensinck JW, Ricketts H, Kendall JW, Williams RH. Insulin and ACTH production by a streptozotocin responsive islet cell carcinoma. Am J Med 1973; 55: 567.
7. Hammar S, Sale G. Multiple hormone producing islet cell carcinomas of the pancreas. Hum Pathol 1975; 6(3): 349-362.
8. Ohneda A, Otsuki M, Fujiya H, Yaginuma N, Kokubo T, Ohtani H. Diabetes 1979; 28: 962.
9. Asa S, Kovacs K, Killinger DW, Marcon N, Platts M. Pancreatic islet cell carcinoma producing gastrin, ACTH, α-endorphin, somatostatin and calcitonin. Am J Gastroenterol 1980; 74: 30-35.
10. Vieweg WVR, Graber AL, Cerchio GM. Pancreatic islet cell carcinoma with hyperinsulinism and probably ectopic ACTH-MSH secretion. Arch Intern Med (Chicago) 1969; 124: 731.
11. Curnow RT, Carey RM, Taylor A, Johanson A, Murad F. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma. New Engl J Med 1975; 292: 1385-1386.
12. Souquet JC, Sassolas G, Forichon J, Champetier P, Partenzky C, Chayvialle JA. Clinical and hormonal effects of a long-lasting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome. Cancer 1987; 59: 1654-1660.
13. Bertagna X, Favrod-Coune C, Escourolle H, Beuzeboc P, Christoforov B, Girard F, Luton JP. Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide. J Clin Endocrinol Metab 1989; 66(5): 988-991.